Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radioimmunoscintigraphy of human colon cancer xenografts in mice with radioiodinated monoclonal antibody B72. 3

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5989843
Monoclonal antibody B72.3 reacts with a tumor-associated antigen that is found on human breast and colon carcinomas in significantly higher concentration than in normal adult tissues. Intact B72.3 lgG was labeled with I-131 or I-125 and injected into athymic mice bearing xenografts of human colon cancer. Whole-body scintiphotos obtained with a pinhole collimator demonstrated tumor localization within 24 hr after intravenous administration, and the tumor-to-background ratio rose continuously for at least 14 days. Progressive antibody accumulation was observed in the tumor during the first 3 days, but no significant normal organ localization was observed at any time. No localization was seen in control tumors, a human melanoma xenograft that lacks the antigen recognized by B72.3. The pharmacokinetics of this antibody in tumor-bearing mice suggest that I-131 B72.3 may be useful for radioimmunotherapy as well as radioimmunoscintigraphy of colon cancer in man.
Research Organization:
National Institutes of Health, Bethesda, MD
OSTI ID:
5989843
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 25:11; ISSN JNMEA
Country of Publication:
United States
Language:
English